Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages
Authors:
Open Access
- 14 May 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0126650
Abstract
Human influenza viruses are responsible for annual epidemics and occasional pandemics that cause severe illness and mortality in all age groups worldwide. Matrix protein 2 (M2) of influenza A virus is a tetrameric type III membrane protein that functions as a proton-selective channel. The extracellular domain of M2 (M2e) is conserved in human and avian influenza A viruses and is being pursued as a component for a universal influenza A vaccine. To develop a M2e vaccine that is economical and easy to purify, we genetically fused M2e amino acids 2–16 to the N-terminus of pVIII, the major coat protein of filamentous bacteriophage f88. We show that the resulting recombinant f88−M2e2-16 phages are replication competent and display the introduced part of M2e on the phage surface. Immunization of mice with purified f88−M2e2-16 phages in the presence of incomplete Freund’s adjuvant, induced robust M2e-specific serum IgG and protected BALB/c mice against challenge with human and avian influenza A viruses. Thus, replication competent filamentous bacteriophages can be used as efficient and economical carriers to display conserved B cell epitopes of influenza A.Keywords
This publication has 62 references indexed in Scilit:
- A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated ChickensVeterinary Medicine International, 2013
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control StudyPLOS Medicine, 2011
- Influenza Virus M2 Protein Mediates ESCRT-Independent Membrane ScissionCell, 2010
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesProceedings of the National Academy of Sciences, 2010
- Influenza virus activates inflammasomes via its intracellular M2 ion channelNature Immunology, 2010
- Engineering filamentous phage carriers to improve focusing of antibody responses against peptidesVaccine, 2010
- Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with LysosomesCell Host & Microbe, 2009
- Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 VirusPLOS ONE, 2009
- Vaccines for preventing influenza in healthy children2008
- An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2Journal of Biological Chemistry, 2008